cdmo.directory
← Compare landing

Avid Bioservices vs Scinai Immunotherapeutics Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/avidbio/scinai-immunotherapeutics

CategoryAvid BioservicesScinai Immunotherapeutics Ltd.
Listed sitecdmoboth
SummaryAvid Bioservices is a U.S.-based mammalian cell culture CDMO providing integrated process development, analytical development, and CGMP biologics manufacturing from DNA to IND to commercial supply, with 30+ years of expertise and FDA-inspected facilities in California.Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.
Services
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Technology Transfer
  • Upstream Processing
  • Downstream Processing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Biologics Development & Manufacturing
  • CMC Analytical Development
  • Process Development
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
IndicationsData not yet provided.
  • Dermatology
  • Immunology
  • Rare Disease
Locations
  • Headquarters & CGMP Manufacturing, Tustin, California, United States
  • Early-Phase Center of Excellence, Costa Mesa, California, United States
  • Headquarters, Jerusalem, Israel
  • Yavne CDMO Facility, Yavne, Israel
CertificationsData not yet provided.
  • EMA · Identifier: European QP (EMA) audit passed
  • Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.